A detailed history of First Horizon Advisors, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 470 shares of TAK stock, worth $6,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
470
Previous 470 -0.0%
Holding current value
$6,509
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$13.89 - $15.04 $1,458 - $1,579
-105 Reduced 18.26%
470 $6,000
Q4 2023

Feb 06, 2024

BUY
$13.36 - $15.43 $2,511 - $2,900
188 Added 48.58%
575 $8,000
Q3 2023

Oct 27, 2023

BUY
$15.03 - $16.32 $1,262 - $1,370
84 Added 27.72%
387 $5,000
Q2 2023

Aug 03, 2023

SELL
$15.57 - $17.11 $15,025 - $16,511
-965 Reduced 76.1%
303 $4,000
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $10,008 - $10,794
655 Added 106.85%
1,268 $20,000
Q4 2022

Feb 10, 2023

BUY
$12.42 - $15.62 $3,105 - $3,905
250 Added 68.87%
613 $9,000
Q2 2022

Aug 02, 2022

BUY
$13.12 - $15.03 $4,316 - $4,944
329 Added 967.65%
363 $5,000
Q1 2022

May 10, 2022

SELL
$13.54 - $15.35 $5,971 - $6,769
-441 Reduced 92.84%
34 $0
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $7,041 - $7,456
432 Added 1004.65%
475 $7,000
Q3 2021

Nov 09, 2021

SELL
$16.3 - $17.26 $16,935 - $17,933
-1,039 Reduced 96.03%
43 $0
Q2 2021

Aug 09, 2021

BUY
$16.55 - $18.64 $9,615 - $10,829
581 Added 115.97%
1,082 $18,000
Q1 2021

May 11, 2021

BUY
$16.71 - $19.9 $835 - $994
50 Added 11.09%
501 $9,000
Q3 2020

Nov 12, 2020

BUY
$17.1 - $19.19 $7,712 - $8,654
451 New
451 $8,000
Q2 2019

Aug 05, 2019

SELL
$16.58 - $20.49 $3,514 - $4,343
-212 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$16.7 - $21.52 $3,540 - $4,562
212 New
212 $0
Q4 2018

Feb 11, 2019

SELL
$15.64 - $21.1 $1,016 - $1,371
-65 Closed
0 $0
Q4 2017

Jan 25, 2018

SELL
$26.96 - $28.56 $134 - $142
-5 Reduced 7.14%
65 $0
Q2 2017

Aug 14, 2017

BUY
N/A
70
70 $0

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.